In addition, miR-326 and miR-27a inhibited GSH levels in cancer cells via targeting other factors such as pyruvate kinase m 2 (PKM2), SLC7A11 and zinc finger and BTB domain containing 10 (ZBTB10)41–43. This evidence concerns the gene ZBTB10 and cancer.